Preconditioning may find ready applicability in humans facing scheduled global cardiac ischemiareperfusion (IR) during bypass or transplantation, where such a maneuver is feasible before arrest. Our objective was to delineate and exploit the endogenous preconditioning mechanism triggered by transient ischemia (TI) and thereby attenuate myocardial postischemic mechanical dysfunction by clinically acceptable means. Preconditioning by 2 minutes of TI followed by 10 minutes of normal perfusion protected isolated rat left ventricle function assessed after 20 minutes of global, 37°C ischemia and 40 minutes of reperfusion. Final recovery of developed pressure (DP) was improved (91.5±l.9%o of equilibration DP versus unconditioned IR control, 57.4+2.4%, P<.01) and was accompanied by increased contractility (±dP/dt). Norepinephrine release increased after TI, and reserpine pretreatment abolished TI preconditioning. This suggests that endogenous norepinephrine mediates functional preconditioning in rat. Brief pretreatment (2 minutes) with exogenous norepinephrine reproduced the protection (89.1+1.4%) of postischemic function. Functional protection persisted after the hemodynamic effects had resolved. Norepinephrine-induced preconditioning was simulated by phenylephrine and blocked by al-adrenergic receptor antagonist. TI preconditioning was similarly lost after selective ovl-adrenergic receptor blockade. We conclude that transient ischemic preconditioning is mediated by the sympathetic neurotransmitter release and at,-adrenergic receptor stimulation. Although the postreceptor mechanism remains unclear, functional protection after IR does not seem related to the magnitude of ATP depletion and elevation of resting pressure during ischemia. Rather, the endogenous mechanisms facilitate both recovery of mechanical function and ATP repletion during reperfusion. (Circ Res. 1993;73:656-670.) KEY WoRDs * adaptation * preconditioning mechanism * myocardial function * norepinephrine * cl-adrenergic receptors * ATP * rat heart T he high rate of energy turnover in myocardial tissue renders the heart very susceptible to ischemia.' Although perfusion must be restored to preserve myocardial function and viability, reperfusion can itself be deleterious.12 Yet, the 150 000 cardiopulmonary bypass and 1000 heart transplantation operations performed annually necessitate extended periods of myocardial ischemia with subsequent reperfusion. Although myocardial dysfunction becomes progressively irreversible with extended ischemia, brief periods of myocardial ischemia trigger an adaptive response that protects the heart against sustained ischemia and reperfusion.2-4 This "preconditioning" phenomenon suggests that transient ischemia (TI) induces intrinsic changes within the myocardium, thereby enhancing its resistance to subsequent ischemia-reperfusion (IR) injury. These protective changes appear effective against a range of post-IR pathophysiology, including stunning, arrhythmias, and infarction. If this preconditioning effect
T he high rate of energy turnover in myocardial tissue renders the heart very susceptible to ischemia.' Although perfusion must be restored to preserve myocardial function and viability, reperfusion can itself be deleterious.12 Yet, the 150 000 cardiopulmonary bypass and 1000 heart transplantation operations performed annually necessitate extended periods of myocardial ischemia with subsequent reperfusion. Although myocardial dysfunction becomes progressively irreversible with extended ischemia, brief periods of myocardial ischemia trigger an adaptive response that protects the heart against sustained ischemia and reperfusion.2-4 This "preconditioning" phenomenon suggests that transient ischemia (TI) induces intrinsic changes within the myocardium, thereby enhancing its resistance to subsequent ischemia-reperfusion (IR) injury. These protective changes appear effective against a range of post-IR pathophysiology, including stunning, arrhythmias, and infarction. If this preconditioning effect against mechanical dysfunction could be reproduced by benign physiological stimuli (ie, not ischemia) and its protective mechanism(s) delineated, it would be applicable in cardiac bypass and transplantation surgery where such a maneuver is feasible before arrest.
A mechanistic approach is suggested by the relatively greater ischemic tolerance of other organs such as skeletal muscle and the viscera. These organs undergo hypoperfusion caused by sympathetic vasoconstriction during stress (eg, in shock or "flight or fight").5 Our previous results implied that sympathetic adrenergic stimulation promotes survival in stressful situations not only by altering hemodynamics (pressor effects) but also systemic metabolism (eg, glucose or ketone supply/ demand).6 Therefore, we speculated that adrenergic vasoconstriction may also stimulate metabolic adaptations that minimize IR injury. Indeed, recent advances in adrenergic signal transduction7 have delineated enzyme phosphorylations and changes in intracellular Ca2+ compartmentation that regulate diverse aspects of cellular biochemistry besides mechanical function (eg, metabolism). 8, 9 In heart, these include control of myocardial fuel choice,10-12 chemomechanical coupling,13 and mitochondrial efficiency.14 Some of the defects limiting recovery of postischemic myocardial function'1'5 lie precisely in these areas of ineffective energy production and utilization as well as disrupted calcium homeostasis.1, [16] [17] [18] We hypothesized that preconditioning occurs because transient ischemic stress initiates a similar protective sympathetic signal transduction cascade in the heart, beginning with local release of the neurotransmitter norepinephrine from intramyocardial adrenergic neurons. This hypothesis may be conveniently tested in the isolated buffer-perfused heart because (1) it permits the functional quantification of IR injury17 '19,20 ; (2) the neuromuscular junctions are intact in the isolated heart, but the influence of circulating catechols and sympathetic reflexes triggered by fright, pain, or epicardial ischemia21 is eliminated; (3) the adrenergic nerve termini are the sole source of norepinephrine release22; and (4) it mimics the clinical conditions of global cardiac ischemia during cardiopulmonary bypass surgery.
The purposes of this study are (1) to investigate the role of the sympathetic neurotransmitter norepinephrine in mediating cardiac preconditioning induced by TI; (2) to determine whether exogenous norepinephrine pretreatment reproduces functional protection against IR in the absence of transient ischemic stress; (3) if so, to identify the adrenergic receptor transducing preconditioning induced by TI and norepinephrine; and (4) to obtain an energetic correlate of functional protection.
Our findings suggest that a single transient ischemic stimulus to the isolated rat myocardium preconditions mechanical function after global IR via the sympathetic neurotransmitter norepinephrine. The sympathetic preconditioning effect seems to be directly transduced by myocardial a,-adrenergic receptors. However, the preconditioning component of the norepinephrine signal is not related to the pressor effects of norepinephrine but rather to facilitated myocardial reenergization during reperfusion.
Materials and Methods

Materials
Male Sprague-Dawley rats (weight, 325 to 350 g; Sasco, Omaha, Neb) were fed a standard diet and acclimated in a quiet quarantine room for 1 week before the experiments. The animal protocol was reviewed and approved by the 7.4 . A water-filled latex balloon was inserted through the left atrium and adjusted to a left ventricular end-diastolic bration. This preload volume was held constant during the entire experiment to allow continuous recording of the ventricular pressure during IR injury. Pacing wires were fixed to the pulmonary outflow tract, and hearts were paced at 6 Hz (pacer off during drug infusions and ischemia). Ventricular developed pressure (DP, end-systolic minus end-diastolic pressure) and heart rate for rate-pressure product calculation were continuously recorded with a pressure amplifier and direct differentiator to obtain ±dP/dt (Gould Electronics, Houston, Tex). Paced hearts that did not produce 105 +25 mm Hg DP at 6 mm Hg LVEDP were discarded. A three-way stopcock above the aortic root was turned to create global ischemia, and the heart was placed in a saline bath held at 37°C. Pacing (6 Hz) was resumed 3 minutes after the start of reperfusion, and the hearts were defibrillated when necessary. Coronary flow was measured in graduated cylinders at intervals before, during, and after infusion (as well as reperfusion).
Experimental Design and Statistical Analysis
All experiments lasted a total of 80 minutes (Table 1) , beginning with a mandatory equilibration period (8 minutes). Control groups included (1) hearts perfused for 80 minutes to ensure preparation stability, (2) hearts perfused for 20 minutes followed by a standard IR insult (20 minutes of ischemia, 40 minutes of reperfusion), and (3) hearts treated with preconditioning stimuli for 2 minutes (transient global ischemia, norepinephrine or phenylephrine infusion) after 8 minutes of equilibration followed by 70 minutes of uninterrupted perfusion.
To assess preconditioning, hearts in group 4 were first equilibrated for 8 minutes, then exposed to the preconditioning stimulus for 2 minutes followed by 10 minutes of normal perfusion (the preconditioning window). Thereafter, preconditioned hearts were subjected to the standard IR insult (20 minutes of ischemia, 40 minutes of reperfusion).
Drugs used to block preconditioning (phentolamine, BE-2254, SPT) were infused for a total of 7 minutes and terminated at least 5 minutes before the onset of sustained ischemia. Reserpine 0.15 mg/kg was given intraperitoneally 24 hours beforehand. Animals appeared healthy and did not lose weight after reserpine injection. Controls for these blockers (group 5) were not exposed to preconditioning stimuli but were subjected to the standard IR insult. In group 6, blocker infusion spanned the preconditioning stimulus. With 2 minutes of TI as the preconditioning stimulus, blockers were infused for 2 minutes before TI and resumed for another 5 minutes during perfusion in the preconditioning window. With 2 minutes of drug infusion as preconditioning stimulus, blockers were infused for 2 minutes before, coinfused for 2 minutes, and then maintained for another 3 minutes during the preconditioning window.
In ECGs were recorded in three groups of rats (control, preconditioned with TI, and preconditioned with phenylephrine, n=6 each), and reperfusion arrythmias were analyzed in a blinded manner for the incidences of ventricular tachycardia (VT) and ventricular fibrillation (VF) before pacing (started at 3 minutes after reperfusion), the time to establishment of paced rhythm (for at least 50 beats), and the incidence of VF after initial conversion to paced rhythm. All analyses were carried out in accordance with the Lambeth Conventions. 23 Functional parameters at identical time points were compared between groups by ANOVA (Tables 2  through 6 ). If the F ratios were significant, BonferroniDunn post hoc test was applied to assess significance (P<.05). In Table 7 . Determinant analysis showed that using repeated measures (ie, matching all parameters to their baseline values) substantially reduced the noise caused by interanimal variability. Thus, the effect of the experiment on the outcome could be more easily discerned. Among the matched functional parameters (expressed as percent of baseline, to emphasize recovery), the %DP was generally the most consistent (largest differences and smallest variance) ( Table 7) . Fig 1 shows the time course of %DP in TI-preconditioned (TI+IR) hearts and ±IR injury controls. Contractile function was <5% of equilibration DP at the end of 2 minutes of TI, but these hearts recovered normal function within 5 minutes of resumed perfusion (Fig 1, Table 3 ). Comparison between hearts subjected to 2 minutes of TI and then simply perfused throughout (TI-IR, Fig 5) Transmission by Norepinephrine The sympathetic preconditioning hypothesis was examined in four steps (addition, blockade, measurement, and depletion). We first explored the effect of brief exogenous norepinephrine preexposure on the outcome after IR. Direct norepinephrine infusion into the heart, also for 2 minutes, replaced preconditioning by 2 minutes of TI. Norepinephrine increased DP, +dP/dt, and -dP/dt rapidly (Fig 2, Table 3 ), but these inotropic effects declined with cessation of norepinephrine infusion and resolved to prestimulation levels before the onset of ischemia. The LVEDP decreased, and the coronary flow increased briefly (Table 3) . After sustained IR, the final %DP recovered showed a dose response to norepinephrine concentrations, peaking when preconditioned with 10 nmol/min. Norepinephrine (Fig 3, left) before protection was abruptly lost. We also determined the optimal duration of the precondi-°N NE nmol/mln (2 minutes) tioning window (ie, recovery period between TI and sustained ischemia) (Fig 3, right) . Preconditioning develops to maximum over about 10 minutes. Induction was faster with exogenous norepinephrine, consistent with its role as mediator of TI (Fig 3, right) . The lack of differences in final function between norepinephrinetreated, nonischemic control hearts (norepinephrine-IR) (Fig 2) and the control-IR group (Fig 1, Table 2 ) suggests that improved function after reperfusion is not a result of the persistence of the hemodynamic effects of norepinephrine (Fig 2, Tables 3 and 7) . Final function in the norepinephrine+IR group is similar to that in nonischemic controls, indicating that exogenous norepinephrine pretreatment, like TI preconditioning, must attenuate some aspects of IR injury. The receptor transducing the protective effects of optimal norepinephrine infusion was identified by selective antagonists and corroborating agonists.7 The nonspecific a-adrenergic receptor antagonist phentolamine7,26 (450 nmol/min, 7 minutes) itself had no effect on functional recovery after IR (Table 4) protection induced by norepinephrine (Table 5) . Pretreatment with the soluble a1-adrenergic receptor selective antagonist BE-22547 (20 nmol/min, 7 minutes) also had no effect on the outcome after straightforward IR injury (Table 4 ) but ablated functional preconditioning by norepinephrine (Table 5 (Tables 3 and 7) . Phenylephrine infusion decreased flow (about 8% from individual heart baseline) and increased +dP/dt modestly. In contrast to norepinephrine, increases in DP were slower and were sustained longer but again were not different from baseline by the onset of ischemia (Table 3) . We then examined the role of norepinephrine and a,-adrenergic receptors in mediating TI preconditioning. Pretreating rats 24 hours ahead with reserpine730 (0.15 mg/kg IP) assessed the effect of partially depleted neurotransmitter stores on preconditioning. Reserpine did not exacerbate or protect IR injury (Table 4) but abolished the preconditioning provided by 2 minutes of TI (Fig 5, Table 6 ). We also reconfirmed previous suggestions that adrenergic neurons release norepinephrine in response to brief ischemic stress. 31 The total coronary effluent obtained during the 10-minute window before ischemia contained a background of 0.48+±0.02 pmol/mL norepinephrine. After 2 minutes of transient global ischemia, norepinephrine concentration in effluent accumulated over the same preconditioning window was 3.76+0.36 pmol/mL (n=3 in each case). In support of our hypothesis that norepinephrine is the primary messenger transmitting TI preconditioning, reserpine pretreatment did not block functional preconditioning by exogenous norepinephrine (which bypasses the release step) (Fig 4, Table 5 ).
Although transient global ischemia is a complex stimulus that certainly includes diverse effects other than neurotransmitter release, our data show that a,-adrenergic receptors are crucial to TI preconditioning. Both phentolamine and BE-2254 (infused 2 minutes before and for 5 minutes after TI) attenuated functional protection to control+IR levels ( Fig 5, Table 6 ). Blocker controls were designed with a similar 5-minute washout period during the latter half of the conditioning window, to avoid possible confounding effects of a-adrenergic receptor antagonists persisting into ischemia.
Preconditioning Effects on Arrhythmias
Several investigators have observed that preconditioning with TI reduces the incidence of arrhythmias in models of regional IR. [31] [32] [33] [34] [35] We found that preconditioning with either TI or phenylephrine did not seem to significantly affect the incidence of VT or VF during the first 3 minutes of reperfusion ( (Fig 3, right) . Reports also suggest that ischemia-induced preconditioning wears off after a few hours.35,46 Thus, unlike heat stress,47 the protection offered by ischemic preconditioning does not seem to be dependent on induction of the synthesis of new proteins. 48 Liu et a149 and Thornton et a150 have proposed that adenosine A1 receptors mediate TI preconditioning, measured by reduced infarction. Although a different TI protocol also attenuated arrhythmia in rats,33 attenuation of functional depression by the adenosine mechanism remains elusive.3337 We have recently suggested that, although an adenosine mechanism may be involved in transient TI preconditioning, it does not mediate the a1-adrenergic receptor-mediated preconditioning described here. 51 The mechanism by which protection is actually implemented is also unclear but could redress injurious aspects of ischemia, reperfusion, or both. Studies report that preconditioned hearts preserve high-energy phosphates during ischemia while reducing glycolytic flux and lactate accumulation4'52'53 and reenergize faster during the reperfusion phase340 (Fig 6) .
Ionic (H', K', Ca2+) mechanisms for attenuating ischemic injury are being proposed and disputed.39'42'52'54 '55 
Sympathetic Preconditioning Cascade
The fact that prior ischemia induces preconditioning suggests that the myocardium possesses intrinsic mechanisms of protection that can be recruited. Evidence that TI-induced protection is receptor mediated supports this view. We reasoned that an initial transient ischemic stress must activate a cascade of endogenous mechanisms that sense brief ischemia, transduce the signal, and implement protective changes that become apparent after IR.2 Remarkably, all these functions are carried out even in isolated buffer-perfused hearts.
Sensing and transmission ofthe TI stimuli. TI enhances norepinephrine release, and TI preconditioning is attenuated by reserpine. This suggests that preconditioning after TI involves the adrenergic nerve termini of the isolated heart. Although the TI episode affects all myocardial structures, the involvement of the sympathetic neurotransmitter suggests that the adrenergic nerve termini sense TI stress and respond by releasing norepinephrine. Protection by TI and norepinephrine could be a positive process, involving the generation of an adaptive signal. Alternatively, norepinephrine release may be defensive, attenuating ischemic injury by a form of "chemical stunning" or norepinephrine depletion, thereby reducing catecholamine toxicity (Fig 7) . This is because ischemically stimulated norepinephrine release is bimodal.22 Brief ischemia stimulates the sympathetic termini to release neurotransmitter norepinephrine by a locally regulated, exocytotic process (the signaling mode) that requires Ca 2+ and ATP. However, 10 minutes or more of ischemia precipitates uncontrolled leakage of norepinephrine (cardiotoxic mode), which could be degraded to noxious metabolites that exacerbate postischemic myocardial necrosis. Furthermore, excessive adrenergic receptor stimulation can accelerate myocardial oxygen debt, energy depletion, Ca 2+ overload, and arrhythmogenicity. 22, 56, 57 However, decreased catecholamine toxicity by norepinephrine release and washout after TI57 is not likely to be the mechanism of TI preconditioning. Recently, Matsuki et a158 reported that depletion of endogenous catecholamines by chemical sympathectomy did not reduce experimental infarcts in rabbits. Similarly, we did not observe improved postischemic function in rats pretreated with reserpine (Tables 4 and 7) , and the norepinephrine release after TI was nominal (<3% of the estimated content in rat heart). In contrast to TI and reserpine, brief exogenous norepinephrine infusion may preserve or even enhance neurotransmitter stores. Norepinephrine both is taken up rapidly into neuronal stores and prevents endogenous neurotransmitter release via presynaptic a-adrenergic receptors. Since exogenous norepinephrine (albeit at optimum dose, Fig 3,  (Fig 7) . Adaptive tolerance to subsequent IR insult evidently persists even after the hemodynamic effects have resolved (Fig 2, Table 3 ) but at present can be unmasked only after an IR insult.
Preconditioning by a,-adrenergic mechanisms. In these isolated rat heart studies, a1-adrenergic receptors (generally postsynaptic7,26,30) seem to predominate in the transduction of preconditioning. Although TI and norepinephrine are multifactorial agents exerting diverse effects on the heart, preconditioning induced by either TI or exogenous norepinephrine was blocked by selective a1-adrenergic receptor antagonist (Tables 5 and 6 ). Therefore, potential contributions from other components of either TI or norepinephrine appear insufficient. (20 nmol/min) were infused for 2 minutes before, coinfused 2 minutes with, and continued 3 minutes after NE. Reserpine (0.15 mg/kg IP) was administered 24 hours ahead. Pacer (5 Hz) was off during NE and the first 3 minutes of reperfusion.
*Different from CTRL+IR (Table 4) and from corresponding blocker+-R (Table 5) , P<.05. Presynaptic a1-adrenergic stimulation might feedbackditioning remain unidentified, the evidence does not inhibit norepinephrine release,726 but as discussed favor the hemodynamic interpretation but rather a above, mechanisms for attenuating norepinephrine redistinct mechanism) and (2) direct a,-adrenergic effect lease seem unlikely to be involved. Therefore, we infer on the regulation of myocardial metabolism (accompathat phenylephrine mimics norepinephrine by directly nying but independent of hemodynamics) that upregustimulating postsynaptic a1-adrenergic receptors, which lates resistance against IR injury. then transduce preconditioning. Similarly, although In regard to preconditioning by coronary vasoconblockade of inhibitory presynaptic a2-and a1-adrenergic striction, coronary flow was not significantly increased receptors could potentially exacerbate norepinephrine after norepinephrine (combined f8-and a-adrenergic release,7,26 pretreatment with a-adrenergic blockers did agonist)60 but was transiently decreased after phenylnot provide protection at the doses used. Rather, these ephrine (predominantly a1-adrenergic agonist) infusion. prevented TI-or norepinephrine-induced preconditionAlthough it is pharmacologically impossible for norepiing, consistent with the inhibition of postsynaptic a1-nephrine and phenylephrine to induce a total no-flow adrenergic receptors. condition, the a1,2-adrenergic component of norepiThe evidence provided above suggests that implenephrine and phenylephrine could have approximated a mentation of protection involves the effectors of the degree of local ischemia. Thus, measurement of total a1-adrenergic pathway. At least two broad classes of coronary flow alone cannot exclude the possibility of mechanisms could be involved (Fig 7) : (1) improved microcirculatory hypoperfusion. However, even total postischemic function secondary to the hemodynamic global ischemia was not sufficient to induce precondieffects of initial a1-adrenergic stimulation, which could tioning in the presence of a1-adrenergic receptor blockinclude coronary vasoconstriction creating transient loade (Table 6 , Fig 5) . Also, a1-adrenergic receptor cal ischemia or persistence of inotropic changes that blockade (which is not as efficient as a2-adrenergic appear to improve postischemic function (although the receptor blockade against norepinephrine-induced vapostreceptor steps implementing a,-adrenergic preconsoconstriction7,26) was nevertheless sufficient for block- receptors. Our demonstration of sympathetic preconditioning is mechanistically different. (1) Transient norepinephrine induced preconditioning under normoxic conditions. As shown in Fig 3, right, preconditioning against subsequent IR developed in the normal perfusion window before ischemia, even as the inotropic effects were subsiding (Fig 2) . (2) a1-Adrenergic receptor blockade did not exacerbate myocardial dysfunction (on the contrary, we and others have found that high doses of the a,-antagonist BE-2254 can be protective). Our preliminary results also suggest that in rats, aladrenergic receptor-mediated preconditioning does not involve adenosine receptors. 51 In regard to preconditioning by persistence of inotropic changes, the mechanism of preconditioning with the optimum dose of norepinephrine could involve residual inotropy resulting from adrenergic stimulation of the heart and phosphorylations of contractile proteins. The persistence of such changes into reperfusion seems unlikely, since contractile parameters (±dP/dT, heart rate, and DP) normalized within 10 minutes after infusions had ceased (ie, before sustained ischemia; Fig  2, Table 3 ). Control groups subjected to the preconditioning stimuli (TI, norepinephrine, phenylephrine) were not functionally different from unconditioned hearts after uninterrupted perfusion for 80 minutes (the corresponding end point in IR groups, Table 7 ). However, after preconditioning, postreperfusion contractility (+ dP/dT) and relaxivity (-dP/dT) were correlated to the improvements shown by developed pressure in Table 7 . Last, although BE-2254 blocked the a,-mediated preconditioning effects of norepinephrine, the potent cardiodynamic ,B-adrenergic effects of norepinephrine were evident but did not induce protection.
In regard to preconditioning by a,-adrenergic regulation of myocardial metabolism, although a,-adrenergic receptor stimulation is usually interpreted in terms of the prominent hemodynamic effects, advances in signal transduction implicate these receptors in multiple effects, including hypertrophic and metabolic remodeling.7-9 Primarily, a,-adrenergic signal transduction involves the increase of intracellular Ca2+ and activation of protein kinase C.7,12.22.64 These effectors regulate numerous aspects of cell function that could either confer tolerance toward ischemic deenergization or facilitate reenergization during reperfusion. a,-Adrenergic receptor stimulation increases glycolytic flux by activating phosphofructokinase activity.'2 Anaerobic energy production from glycogenolysis and glycolysis could produce superior tolerance to ischemia, but glycogen breakdown and ATP loss after 20 minutes of ischemia were identical with and without TI or norepinephrine preconditioning (Fig 6) . Other studies show that TI preconditioning in dogs4,53 and pigs52 slows the initial rate of ATP loss particularly at 10 minutes of ischemia but not thereafter. Anaerobic glycolysis has been linked to ischemic contracture in rats,65 but we found no difference in the time to ischemic contracture sensitization may lower or obviate the need to release norepinephrine. Although the effectors of the a,-adrenergic pathway might also be stimulated by other receptors89 or distal agonists in isolated rat heart, TI preconditioning seems to use the a1-adrenergic pathway preferentially. (4) When preconditioning with noxious stimuli such as ischemia, an optimum is to be expected. The dose response of preconditioning by norepinephrine (Fig 3, left) also shows an optimum. Loss of protection at higher doses of norepinephrine is consistent with its potential for cardiotoxicity and arrhythmogenicity in the setting of IR.22,285657 As revealed by high doses of BE-2254, excessive a1-adrenergic receptor stimulation could contribute to ischemic calcium overload and injury.68,69 Note that presynaptic receptors and ion fluxes (some triggered by tissue deenergization, eg, adenosine A1 or Ca2`) modulate norepinephrine release and adrenergic transduction.22'70 Therefore, experimentally observed optimums of TI or norepinephrine should differ among preconditioning models (ie, buffer versus blood perfused, isolated versus intact, constant load versus constant flow) according to energy supply and demand and adrenergic tone. This concept may also apply to an optimum window between the preconditioning stimulus and the sustained ischemic challenge. The need for a normally perfused preconditioning window may reflect the intrinsic energy dependence of a1-adrenergic receptor signal transduction (protein kinase C phosphorylation, ion fluxes). However, after prolonged ischemia, lowered free energy of ATP hydrolysis (and/or high catabolite concentrations) could preclude or mask the adaptive response. The gradual appearance of protection during the conditioning window (Fig 3, right) (and its decay35'46) is consistent with such an energy-dependent phosphorylation/dephosphorylation process lying distal to the a1-adrenergic receptor.
Generalization of our results to other species requires caution. Support for the a1-adrenergic receptor mechanism appears in dogs, in which TI preconditioning against infarction can be blocked and stimulated at a1-adrenergic receptors. 71 In rabbits too, the depletion of endogenous norepinephrine stores by reserpine seems to negate TI-induced preconditioning against infarction.72 However, functional preconditioning by TI appears to be effective in rats37-39,42 and rabbits36 but not dogs. 43 The primacy of a1-adrenergic receptors or adenosine A1 receptors in the preconditioning mechanism may reflect the divergent evolution of signaling pathways and protective optima in these species. Indeed. Endoh et a64 have described that a1-adrenergic receptor-stimulated inositol triphosphate (IP3) formation occurs in rat hearts but not in rabbit or dog hearts. Significantly, Kohl et a173 have found increases in 1P3 in human heart tissue after phenylephrine stimulation.
We conclude that the mechanism of ischemic preconditioning involves the a1-adrenergic effect of the neurotransmitter norepinephrine, which enhances functional and metabolic recovery after IR (Fig 6) . This conclusion is drawn from the observations that (1) a single, transient (2-minute) ischemic episode is sufficient to precondition myocardial function; (2) the preconditioning mechanism involves release of norepinephrine by intramyocardial adrenergic neurons and is susceptible to reserpine pretreatment; (3) functional cardioprotection can be reproduced by two different a1-adrenergic agonists (norepinephrine or phenylephrine); (4) functional preconditioning by either TI or norepinephrine is inhibited by selective a1-adrenergic blockade; and (5) preconditioning facilitates reenergization (ATP repletion) during reperfusion.
